Episode 106: Colorectal Cancer Series, Pt. 8 - Early Onset Colorectal Cancer
In a recent American Cancer Society publication, there are increasing data that rates of colorectal cancer are rising rapidly among people in their 20s, 30s and 40s. This has certainly caught the attention of the lay press, most recently in a widely circulated New York Times article published in March 2024. Today, we welcome Dr. Chris Cann, who is an Assistant Professor of Hematology/Oncology at the Fox Chase Cancer Center in Philadelphia where he focuses on GI oncology and has a particular area of interest in early onset colorectal cancer. In his short career thus far, Dr. Cann is already making a name for himself in this space on a national level and so we are so glad he was able to join us for this special discussion. Dr. Cann sheds light on what we know and what we don’t know about this phenomenon. Definitely an episode to check out!
About our guest
Dr. Chris Cann is an Assistant Professor, Department of Hematology/Oncology at Fox Chase Cancer Center in Philadelphia, PA where he is a part of the Gastrointestinal Cancer Program. Dr. Cann completed his undergraduate training at University of Maryland after which he received his MD at The Lewis Katz School of Medicine at Temple University. He then moved to Nashville, TN to complete his internal medicine residency and hematology/oncology fellowship at Vanderbilt University Medical Center. Dr. Cann has an area of interest in early onset colorectal cancer and has published and presented on this topic on a national level. In addition to his academic accolades, Dr. Cann is a diehard Philadelphia Eagles fan #GoBirds.
The crew behind the magic:
Show outline: Ronak Mistry
Production and hosts: Ronak Mistry, Vivek Patel, Dan Hausrath
Editing: Resonate Recordings
Shownotes: Ronak Mistry
Social media management: Ronak Mistry
